HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$3.33
Day range
$3.04 - $3.50
Year range
$2.44 - $6.16
Market cap
27.08M USD
Avg Volume
36.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.93M | 647.66% |
Operating expense | 4.33M | 206.22% |
Net income | -2.31M | 22.59% |
Net profit margin | -119.84 | 89.65% |
Earnings per share | -0.26 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.00M | -48.50% |
Total assets | 10.91M | -44.01% |
Total liabilities | 3.46M | 24.51% |
Total equity | 7.45M | — |
Shares outstanding | 8.92M | — |
Price to book | 3.96 | — |
Return on assets | -53.13% | — |
Return on capital | -69.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.31M | 22.59% |
Cash from operations | 1.20M | 206.21% |
Cash from investing | — | — |
Cash from financing | 1.70K | -99.65% |
Net change in cash | 1.20M | 285.01% |
Free cash flow | 1.95M | 1,441.28% |
About
Founded
1992
Headquarters
Website
Employees
8
